Lonza signs agreement with Index Ventures for development and manufacture of biologics
07:04 AM | January 9, 2014 | Deepti Ramesh
Lonza and Index Ventures, a leading venture capital investment firm, have signed an exclusive five-year agreement for process development and cGMP production for all biological products in the...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.